Literature DB >> 31775446

[The regulatory effect of GAPLINC in malignant tumors and its relationship with the prognosis of patients].

Y S Zhou1, S W Xu, C H Guan, Z T Hu, X M Jiang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31775446     DOI： 10.3760/cma.j.issn.0529-5807.2019.11.017

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN： 0529-5807


× No keyword cloud information.
  2 in total

1.  LncRNA GAPLINC Promotes Renal Cell Cancer Tumorigenesis by Targeting the miR-135b-5p/CSF1 Axis.

Authors:  Siyuan Wang; Xiaorong Yang; Wenjie Xie; Shengqiang Fu; Qiang Chen; Zhilong Li; Zhicheng Zhang; Ting Sun; Binbin Gong; Ming Ma
Journal:  Front Oncol       Date:  2021-10-14       Impact factor: 6.244

2.  Analysis of Threshold Changes of Tumor Mutation Burden of Gastric Cancer and Its Relationship with Patients' Prognosis.

Authors:  Nan Zhang; Peiyu Li; Xin Wu; Shaoyou Xia; Xudong Zhao; Lin Chen
Journal:  J Oncol       Date:  2021-09-27       Impact factor: 4.375
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.